Line Bjørge
- Obstetrics and Gynecology top 0.5%
- Pregnancy and preeclampsia studies 23
- Endometrial and Cervical Cancer Treatments 23
- Reproductive Medicine top 1%
- Ovarian cancer diagnosis and treatment 37
- Immunology top 5%
- Reproductive System and Pregnancy 15
- Complement system in diseases 9
-
- Birth, Development, and Health 13
- Oncology top 5%
- PARP inhibition in cancer therapy 12
-
- Cancer Genomics and Diagnostics 10
- Co-authors
- Roald MatreSeppo MeriJone TrovikJuha HakulinenIngfrid S. HaldorsenTone Skeie JensenOle Erik IversenRigmor Austgulen
- Journals
- Acta Obstetricia Et Gynecologica Scandinavica (9 papers)Journal of Clinical Oncology (8 papers)Placenta (7 papers)
- Partner nations
- NorwayUnited StatesSweden
In The Last Decade
Line Bjørge
124 papers receiving 2.9k citations
Peers
Comparison fields: 5 of 124
- Obstetrics and Gynecology 1.0k
- Reproductive Medicine 683
- Immunology 764
- Pediatrics, Perinatology and Child Health 438
- Oncology 583
Countries citing papers authored by Line Bjørge
This map shows the geographic impact of Line Bjørge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Line Bjørge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Line Bjørge more than expected).
Fields of papers citing papers by Line Bjørge
This network shows the impact of papers produced by Line Bjørge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Line Bjørge. The network helps show where Line Bjørge may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Line Bjørge, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 3 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 0 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 3 | |
| 7 | 2024 | 0 | |
| 8 | 2024 | 3 | |
| 9 | 2024 | 0 | |
| 10 | 2023 | 7 | |
| 11 | 2023 | 2 | |
| 12 | 2023 | 4 | |
| 13 | 2023 | 2 | |
| 14 | 2023 | 0 | |
| 15 | 2022 | 32 | |
| 16 | 2021 | 6 | |
| 17 | 2021 | 36 | |
| 18 | 2015 | 52 | |
| 19 | 2012 | 13 | |
| 20 | Patofysiologi og kliniske manifestasjoner ved preeklampsi | 2000 | 0 |
About Line Bjørge
Line Bjørge is a scholar working on Obstetrics and Gynecology, Reproductive Medicine and Immunology, having authored 138 papers that have together received 2.9k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (37 papers), Pregnancy and preeclampsia studies (23 papers), Endometrial and Cervical Cancer Treatments (23 papers), Reproductive System and Pregnancy (15 papers), Birth, Development, and Health (13 papers), PARP inhibition in cancer therapy (12 papers), Cancer Genomics and Diagnostics (10 papers) and Complement system in diseases (9 papers). The work is most often cited by research in Obstetrics and Gynecology (1.0k citations), Reproductive Medicine (683 citations) and Immunology (764 citations). Line Bjørge has collaborated with scholars based in Norway, United States and Sweden. Frequent co-authors include Roald Matre, Seppo Meri, Jone Trovik, Juha Hakulinen, Ingfrid S. Haldorsen, Tone Skeie Jensen, Ole Erik Iversen, Rigmor Austgulen, Øyvind Salvesen and Liv Cecilie Vestrheim Thomsen. Their work appears in journals such as Acta Obstetricia Et Gynecologica Scandinavica, Journal of Clinical Oncology, Placenta, Cancers and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.